A Maryland biotechnology company will receive $1.6 billion in federal funding to help them to continue to develop and hold a clinical trial for a coronavirus vaccine this year.
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US The experimental vaccine, developed by Moderna and the National..
Wibbitz Top Stories